KKR earnings analysis: questions answered and next catalysts

KKR & Co LP (KKR) reported Q3 2026 on Nov 9, 2026 (pre-market). Adjusted net income per share was $1.78 against a $1.59 estimate (+11.95%). Revenue was $4.56B against $2.69B expected, though the revenue comparison is distorted by how the firm books performance income. The stock was at $98.65 (+2.25%) as of 3:04 PM EST. That is still -23.46% YTD and well below its 52-week high of $144.84.

Questions Answered

• Is the fee engine growing? Yes. Management fees were $1.2B, up 16% ex catch-up fees. Fee-related earnings per share rose 24% to $1.42. Total operating earnings per share rose 21% to $1.88.
• Can KKR still raise capital? Yes. It raised $25B in the quarter and $116B over the trailing 12 months. Credit raised $14B. The Global Infrastructure flagship closed at $19.2B, above the prior $17B fund.
• Are exits happening? Management expects more than $40B returned to clients in 2026, over 50% above the prior record, which addresses the monetization worry.
• Is private wealth scaling? K-Series AUM is $45B (+55% year over year). Q3 inflows were $3B (+11% quarter over quarter).
• Is there deployment capacity? The firm deployed $20B in the quarter and holds a record $146B of dry powder.
• Is the beat a one-off? It looks like the second straight record quarter on the three headline metrics, and the results were not just one-time gains. EPS surprises were +3.7%, +14.0% and +12.0% over the last three quarters, after a small miss (-1.75%) in Q4 2025. (Nov 9, 2026)

Still Open

• Transaction revenue is uneven. Capital markets and monetization income swing with markets. Management noted that the 10-year Treasury yield jumped 80 basis points in Q3.
• Portfolio marks are mixed. Private equity was flat, infrastructure rose 4% and opportunistic real estate fell 2%.
• AI infrastructure is early. Management called the opportunity large but uncertain. Samsung committed $1B to the Helix strategy, which has more than $11B in total commitments.
• Estimates have been drifting down. EPS consensus is -1.52% over 90 days and -7.53% over one year. Revenue consensus is -2.98% over 30 days.
• The stock has not re-rated. Investors are still pricing in sector worries: software, private credit, wealth flows and insurance affiliates.

Next Catalysts

• Q4 earnings: scheduled for Feb 9, 2027, with consensus EPS of $3.64 and revenue of $2.97B. The EPS figure is elevated, which suggests a heavy performance-fee quarter.
• Governance change: management expects the move to one share, one vote by the next earnings call, when the co-founders’ super-voting rights sunset.
• Monetization pace: the more than $40B return target and the announced USI transaction.
• Fee turn-on: $75B of uncalled assets that are not yet paying fees, at a blended rate of about 90 basis points. That balance is up 24% since the start of the year.
• Strategic holdings: operating earnings are expected to exceed $350M in 2026.
• Insurance-related capital markets: management said this could become a several-hundred-million-dollar annual revenue stream.
• Forward estimates: FY2026 EPS consensus is $8.23. FY2027 is $7.12, a decline that reflects lumpier performance income.

Bull view: recurring fees are compounding above 15% and exits are running at record levels. Bear view: the stock is down 18.69% over one year despite the growth, so sentiment on private markets is the main headwind, and rate-sensitive deal activity could stay uneven.

Price figures are as of Nov 9, 2026, 3:04 PM EST. Earnings figures are from the Nov 9, 2026 release and consensus data.